Cingulate CING
NASDAQ CING
$5.26 +0.03 (+0.48%)
As of: Sep 22, 2026 · 11:16 AM EDT

Cingulate (CING) Receivables - Net (2023 - 2024)

Cingulate's (CING) quarterly Receivables - Net came in at $2247.0 in Q3 2024, down 99.86% quarter-over-quarter from $1.6 million in Q2 2024.

Analysis

Cingulate (CING) Receivables - Net (2023 - 2024) Analysis & Trends

Cingulate (CING) has reported Receivables - Net for 2 consecutive years, with $2247.0 the latest figure, recorded in Q3 2024.

  • For the quarter ending Q3 2024, Receivables - Net changed N/A year-over-year to $2247.0; the trailing twelve-month figure through Sep 2024 stood at $2247.0 (changed N/A YoY), and the FY2023 full-year result was $14622.0, changed N/A from the prior year.
  • Receivables - Net fell to $2247.0 in Q3 2024 per CING's latest filing, from $1.6 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $1.6 million in Q2 2024 and bottomed at $2247.0 in Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn
10 Cingulate 72.81 Mn 72.81 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 2,247.00
Jun 30, 2024 1.62 Mn
Dec 31, 2023 14,622.00
API Access

Cingulate Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=CING&period=max&api_key=YOUR_API_KEY